GlassScriptPhysician profile
Micia Roby
NPI 1790198141
$434.75
in general payments reported to CMS, 2019-2025
20 companies · $18.30 in 2025
The $18.30 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $89.04 · 2021: $31.84 · 2022: $92.29 · 2023: $72.51 · 2024: $22.96 · 2025: $18.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $48.44 | 2019-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Glaxosmithkline, LLC. | $41.23 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.76 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $31.84 | 2021 | |
| Organon LLC | $30.30 | 2022-2023 | Nexplanon |
| Lilly USA, LLC | $23.38 | 2019 | |
| Sumitomo Pharma America, INC. | $22.96 | 2024 | Myfembree |
| Abbvie INC. | $20.57 | 2023 | Vraylar |
| Takeda Pharmaceuticals U.S.A., INC. | $19.98 | 2020 | |
| Sobi, INC | $19.19 | 2022 | |
| Astellas Pharma US INC | $18.30 | 2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.15 | 2020 | |
| Novo Nordisk INC | $16.04 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.69 | 2020 | |
| Pfizer INC. | $14.57 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $14.20 | 2023 | Quviviq |
| Cranial Technologies, INC | $13.65 | 2019 | |
| Janssen Biotech, INC. | $12.69 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.90 | 2022 | |
| Dynavax Technologies Corporation | $7.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micia Roby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.